Regulatory Affairs Specialists

13-1041.07

Median wage $80,730/yr417,070 employed (US)Rank #261 of 923 scored · top 28% by substitution

Coordinate and document internal regulatory processes, such as internal audits, inspections, license renewals, or registrations. May compile and prepare materials for submission to regulatory agencies.

Sub-scores

0–100 · band = confidence interval from rater disagreement

Substitution35

Exposure37

Augmentation75

Substitution — the headline: capability discounted by cost, barriers and adoption.

Exposure — technical capability alone, regardless of whether anyone deploys it.

Augmentation — how much AI assists without replacing. High here + moderate substitution = a changing job, not a disappearing one.

Tasks on the substitution scale

30 rated tasks, binned by substitution score.

Position among all scored occupations

Distribution of 923 occupation scores; the marker is this occupation.

Tasks with substitution ≥ 70

Run 1.0.0-draft.1 · computed 2026-08-05 · rater panel: claude-sonnet-5, claude-haiku-4-5-20251001 · intervals span rater disagreement.

Why this score

The five weighted dimensions of the composite, averaged across this occupation's tasks (importance-weighted, panel mean). Exact weights and formulas: /api/v1/methodology.

Task automatabilityw 35%39

panel mean rating 2.6/5 → substitution pressure 39/100

Technical feasibility todayw 20%34

panel mean rating 2.4/5 → substitution pressure 34/100

Cost vs. human wagew 15%37

panel mean rating 2.5/5 → substitution pressure 37/100

Adoption barriersw 20%inverted — strong barriers lower the score30

panel mean rating 3.8/5 (barrier strength) → substitution pressure 30/100

Sector adoption velocityw 10%33

panel mean rating 2.3/5 → substitution pressure 33/100

Task breakdown (30 tasks)

Substitution pressure per task, weighted by O*NET importance in the composite. Expand a task for the full rater audit trail — every rating, every model, every rationale.

Compile and maintain regulatory documentation databases or systems.

CI 62–79 · exposure 78 · augmentation 100 · importance 3.8/5 · click for rater detail

Panel ratings per dimension for this task
Dimension	Model	Rating	Rationale
Sector adoption velocity	claude-haiku-4-5-20251001	4/5	Pharma, biotech, and medical device companies are rapidly adopting regulatory information management systems and AI-assisted data curation; this is a high-digitization sector with mature tooling and measurable production deployment in compliance workflows.
Sector adoption velocity	claude-sonnet-5	3/5	Pharma, medical device, and other regulated industries are adopting RIM and AI-assisted document systems steadily, but adoption is more cautious than in fast-moving sectors like finance or general professional services due to compliance risk.
Augmentation potential	claude-haiku-4-5-20251001	5/5	AI systems excel at assisting regulatory specialists by auto-populating fields, flagging inconsistencies, recommending document classifications, and tracking changes—enabling humans to focus on judgment, complex exceptions, and regulatory strategy rather than rote data entry and maintenance.
Augmentation potential	claude-sonnet-5	5/5	AI substantially augments this task by automating extraction, tagging, version control, and search across large regulatory document sets, letting specialists focus on judgment-based compliance decisions.
Task automatability	claude-haiku-4-5-20251001	5/5	Compiling and maintaining regulatory documentation databases is largely a structured data management task—ingesting documents, organizing, tagging, updating records, and ensuring consistency. Current AI systems (document OCR, database automation, RPA tools) can handle these workflows end-to-end with significant time savings at comparable quality.
Task automatability	claude-sonnet-5	4/5	Compiling and maintaining documentation databases is largely structured data entry, organization, and indexing work that current AI systems can perform with substantial time savings, especially with document parsing and metadata extraction tools.
Adoption barriers	claude-haiku-4-5-20251001	3/5	Regulatory documentation systems often require audit trails, version control, and compliance sign-off (FDA CFR 21 Part 11, GMP), creating organizational friction and oversight requirements. However, no hard regulatory mandate requires a licensed human to physically perform the compilation—automation is legally permitted with appropriate controls.
Adoption barriers	claude-sonnet-5	3/5	While no license is strictly required to maintain a database, regulatory submissions often require accountable sign-off and audit trails, creating moderate compliance and liability-driven friction against full automation.
Cost vs. human wage	claude-haiku-4-5-20251001	4/5	AI-driven document management and database automation cost substantially less than human data entry, QA, and maintenance labor; however, integration, training, and regulatory compliance oversight add non-trivial overhead, keeping the ratio favorable but not yet an order of magnitude cheaper.
Cost vs. human wage	claude-sonnet-5	4/5	Automated document management and extraction tools cost a fraction of dedicated specialist labor hours for routine cataloging and updating tasks, though oversight costs somewhat offset savings.
Technical feasibility today	claude-haiku-4-5-20251001	4/5	Mature products exist in regulatory tech (Veeva Vault, MasterControl, Dossier) that perform database compilation and maintenance reliably in production across pharma and life sciences. Minor gaps remain in edge-case document types or highly customized taxonomies, but core capability is proven at scale.
Technical feasibility today	claude-sonnet-5	3/5	Regulatory information management (RIM) software with AI-assisted metadata tagging and document classification exists in production, but full autonomous maintenance of compliance-critical databases still requires human validation for accuracy and regulatory nuance.

Obtain and distribute updated information regarding domestic or international laws, guidelines, or standards.

CI 50–67 · exposure 62 · augmentation 88 · importance 3.5/5 · click for rater detail

Panel ratings per dimension for this task
Dimension	Model	Rating	Rationale
Sector adoption velocity	claude-haiku-4-5-20251001	3/5	Pharmaceutical, financial services, and consumer-goods firms are increasingly adopting automated regulatory tracking; however, adoption is concentrated in large, digitally mature organizations. Smaller firms and heavily regulated sectors still rely heavily on human specialists, limiting overall velocity.
Sector adoption velocity	claude-sonnet-5	3/5	Regulatory affairs and compliance functions are adopting AI monitoring tools steadily but cautiously, given the high stakes of accuracy, placing this in the middle of adoption curves rather than aggressive deployment seen in general professional services.
Augmentation potential	claude-haiku-4-5-20251001	5/5	AI dramatically assists regulatory specialists by surfacing relevant legal changes, filtering noise, auto-summarizing documents, and organizing information by topic and jurisdiction—allowing humans to focus on interpretation, risk assessment, and strategic guidance rather than manual research.
Augmentation potential	claude-sonnet-5	4/5	AI substantially aids specialists by continuously scanning sources, summarizing changes, and flagging relevant updates, meaningfully speeding up an otherwise labor-intensive monitoring process while humans retain responsibility for validation and distribution decisions.
Task automatability	claude-haiku-4-5-20251001	4/5	AI can systematically monitor legal databases, government websites, and regulatory bodies to identify, summarize, and distribute updated laws and guidelines with minimal human intervention. Large language models and web-scraping agents can filter, classify, and route information by jurisdiction and relevance, achieving >50% time savings on the information-gathering and initial distribution pipeline.
Task automatability	claude-sonnet-5	3/5	AI can monitor, retrieve, summarize, and disseminate regulatory updates from databases and websites, but reliable coverage of authoritative sources and jurisdiction-specific nuance still requires human verification and curation to avoid missing or misinterpreting critical changes.
Adoption barriers	claude-haiku-4-5-20251001	3/5	While there are no legal bars to AI gathering and distributing regulatory information, many organizations require human sign-off on compliance guidance for liability reasons, and some regulators expect human judgment in interpreting ambiguous or emerging rules. This creates material but not absolute friction.
Adoption barriers	claude-sonnet-5	3/5	No strict licensing requirement to gather and distribute information, but organizational risk tolerance is low because missing or misreporting a regulatory change carries compliance liability, creating moderate friction around trusting AI outputs without human sign-off.
Cost vs. human wage	claude-haiku-4-5-20251001	4/5	AI-powered regulatory monitoring and distribution systems have substantially lower marginal costs per update than hiring specialists to manually track and synthesize regulatory changes across multiple jurisdictions, though setup and integration costs are non-trivial.
Cost vs. human wage	claude-sonnet-5	3/5	Subscription-based regulatory intelligence tools with AI features cost meaningfully less than a dedicated human tracking all sources manually, but licensing costs plus required human oversight for accuracy keep the ratio closer to comparable than order-of-magnitude cheaper.
Technical feasibility today	claude-haiku-4-5-20251001	4/5	Deployed products (legal research platforms with AI summaries, regulatory monitoring services, and automated alert systems) reliably perform parts of this task in production. However, interpretation of nuanced regulatory changes and jurisdiction-specific applicability still often require human review, preventing a full 5 rating.
Technical feasibility today	claude-sonnet-5	3/5	Regulatory intelligence platforms and AI-powered monitoring tools exist and are used in production (e.g., pharma/medical device compliance software), but they still have gaps in coverage, false negatives, and require human review before distribution to ensure accuracy.

Review product promotional materials, labeling, batch records, specification sheets, or test methods for compliance with applicable regulations and policies.

CI 37–60 · exposure 53 · augmentation 75 · importance 4.3/5 · click for rater detail

Panel ratings per dimension for this task
Dimension	Model	Rating	Rationale
Sector adoption velocity	claude-haiku-4-5-20251001	2/5	Regulatory Affairs remains a conservative, compliance-driven domain with slow digitization outside large pharma and consumer goods firms. While pilot programs exist, production deployment of AI for autonomous compliance review is still uncommon; most organizations retain manual review workflows and view AI as optional augmentation.
Sector adoption velocity	claude-sonnet-5	2/5	Pharma/biotech/medical device regulatory functions are historically slow to adopt automation due to compliance risk and validation requirements, though pilot tools are emerging.
Augmentation potential	claude-haiku-4-5-20251001	4/5	AI significantly enhances specialist productivity by pre-screening documents, highlighting potential non-compliance, and cross-referencing regulatory databases, allowing the human specialist to focus on judgment calls and novel or complex cases. This raises output per specialist without removing human oversight.
Augmentation potential	claude-sonnet-5	4/5	AI is well-suited to accelerate first-pass review, flag inconsistencies, and check text against regulatory language, meaningfully speeding up the specialist's work while they retain final judgment.
Task automatability	claude-haiku-4-5-20251001	4/5	AI can systematically check promotional materials, labels, and documents against known regulatory rules (e.g., FDA labeling requirements, ingredient disclosures) and flag deviations with high accuracy. While final sign-off may require human judgment on novel or ambiguous cases, the core compliance-checking work achieves substantial time savings, likely exceeding 50% for straightforward materials.
Task automatability	claude-sonnet-5	3/5	AI can draft compliance checks and flag likely issues in labeling or promotional text against known regulations, but final review requires nuanced judgment about ambiguous regulatory intent and cross-document consistency that current systems handle unevenly.
Adoption barriers	claude-haiku-4-5-20251001	3/5	Regulatory agencies (FDA, EMA, etc.) often require documented human review and sign-off for critical compliance decisions; AI cannot legally substitute for the final authorization signature. However, AI can perform the bulk of the review work, with human specialists then verifying and signing, creating meaningful friction but not a hard legal bar to automation of the checking itself.
Adoption barriers	claude-sonnet-5	4/5	Regulatory submissions and compliance sign-offs typically require credentialed regulatory affairs professionals to attest accuracy, and errors carry significant legal/regulatory risk, creating strong barriers to full automation.
Cost vs. human wage	claude-haiku-4-5-20251001	4/5	AI inference on document review is inexpensive compared to the fully-loaded cost of specialist labor ($80–120k+/year). Integration and oversight overhead are manageable, making AI cost per review cycle roughly 10–100× cheaper than human review for high-volume batches.
Cost vs. human wage	claude-sonnet-5	3/5	AI can cheaply pre-screen large volumes of text, but the need for human verification of regulatory correctness and liability keeps overall costs closer to parity with human review once oversight is included.
Technical feasibility today	claude-haiku-4-5-20251001	3/5	AI document-review and compliance-checking tools exist in production (e.g., contract-review platforms, regulatory document analyzers), but their performance on this specific domain is narrow and often requires substantial setup and validation against an organization's regulatory baseline. Error rates on edge cases and novel regulations remain material.
Technical feasibility today	claude-sonnet-5	2/5	Some compliance-review copilots and document-comparison tools exist in regulatory affairs software, but they are narrow in scope and not yet demonstrated as fully reliable across the range of materials (promotional, labeling, batch records, specs, test methods) in production.

Identify relevant guidance documents, international standards, or consensus standards.

CI 39–59 · exposure 50 · augmentation 88 · importance 4.3/5 · click for rater detail

Panel ratings per dimension for this task
Dimension	Model	Rating	Rationale
Sector adoption velocity	claude-haiku-4-5-20251001	2/5	Regulatory and compliance functions are among the slowest to adopt autonomous AI systems due to legal, liability, and audit requirements; most adoption remains in pilot or assistive forms rather than replacement, concentrated in larger organizations.
Sector adoption velocity	claude-sonnet-5	3/5	Pharma, medical device, and other regulated industries are adopting AI research tools at a moderate pace, with pilots and some production use in regulatory intelligence but not yet universal deployment.
Augmentation potential	claude-haiku-4-5-20251001	4/5	AI-powered search and summarization tools substantially accelerate a specialist's ability to scan and surface relevant standards and guidance from large databases, enabling faster initial research and broader coverage while the human expert retains critical judgment on applicability and interpretation.
Augmentation potential	claude-sonnet-5	5/5	AI significantly speeds up the discovery and summarization of relevant guidance and standards, letting specialists focus on interpretation and application rather than manual searching.
Task automatability	claude-haiku-4-5-20251001	3/5	AI can search databases and retrieve relevant guidance documents, standards, and regulations with reasonable accuracy, but typically requires human validation and judgment to confirm relevance, prioritize among competing standards, and interpret applicability to specific contexts—limiting the time savings to roughly 50% of the task.
Task automatability	claude-sonnet-5	3/5	AI can search and surface relevant guidance documents and standards quickly, but verifying applicability, recency, and jurisdictional nuance still requires expert judgment, so full end-to-end automation at equal quality is only partially achievable.
Adoption barriers	claude-haiku-4-5-20251001	4/5	Regulatory affairs specialists must authenticate, certify, and often legally sign off on the completeness and correctness of identified guidance documents; liability and compliance obligations mean human accountability cannot be fully eliminated, creating strong adoption friction.
Adoption barriers	claude-sonnet-5	2/5	No licensing requirement blocks AI from doing this identification task, though regulatory affairs work often requires sign-off by a qualified specialist for downstream submissions, creating mild organizational friction.
Cost vs. human wage	claude-haiku-4-5-20251001	2/5	The cost of deployed AI retrieval systems plus integration and required specialist oversight remains comparable to or slightly higher than the hourly cost of a regulatory affairs specialist performing manual searches, given the need for expert human validation of results.
Cost vs. human wage	claude-sonnet-5	4/5	AI-assisted search and retrieval is far cheaper than manual literature/standards review, though some human verification cost remains to ensure accuracy and completeness.
Technical feasibility today	claude-haiku-4-5-20251001	3/5	Document retrieval and search products (RAG systems, regulatory databases with AI indexing) exist in production, but error rates in identifying truly relevant standards remain material, and integration with specialized regulatory databases requires customization; deployments are common but not uniformly reliable at scale.
Technical feasibility today	claude-sonnet-5	3/5	Deployed tools (regulatory intelligence platforms, AI search assistants) exist and are used in practice, but they still have material error rates in identifying the most current or applicable standard, especially across jurisdictions.

Participate in internal or external audits.

CI 28–69 · exposure 53 · augmentation 88 · importance 3.8/5 · click for rater detail

Panel ratings per dimension for this task
Dimension	Model	Rating	Rationale
Sector adoption velocity	claude-haiku-4-5-20251001	4/5	Large enterprises and regulated industries (pharma, finance, healthcare) are rapidly deploying AI-assisted audit tools to manage document volume and speed preliminary reviews. Mid-market and smaller firms lag, but momentum is strong in information and professional services sectors.
Sector adoption velocity	claude-sonnet-5	3/5	Regulatory affairs in pharma/biotech and other regulated industries is moderately adopting AI for documentation and compliance tracking, but audit engagement itself remains largely human-led.
Augmentation potential	claude-haiku-4-5-20251001	5/5	AI excels at augmenting auditors by automating document ingestion, cross-referencing, anomaly flagging, and report generation, freeing specialists to focus on complex findings, stakeholder communication, and judgment-based recommendations. This is a textbook case of AI-as-assistant raising auditor productivity.
Augmentation potential	claude-sonnet-5	4/5	AI can significantly help specialists prepare audit trails, summarize records, flag anomalies, and organize documentation, improving efficiency while humans lead the audit interactions.
Task automatability	claude-haiku-4-5-20251001	5/5	AI can now gather audit evidence, cross-reference regulatory requirements against documentation, identify gaps, generate audit schedules, and produce preliminary audit reports with minimal human correction. Modern LLMs plus document-processing agents can handle 60–80% of audit preparation and documentation review, meeting the 50% time-saving threshold.
Task automatability	claude-sonnet-5	2/5	Audit participation requires interviewing staff, exercising judgment on compliance nuances, and real-time interaction with auditors, which current AI cannot fully replace, though document prep and evidence gathering can be assisted.
Adoption barriers	claude-haiku-4-5-20251001	4/5	Regulatory frameworks and corporate governance often require a licensed or designated human auditor or compliance officer to attest to audit conclusions and sign off on findings. Liability exposure and fiduciary responsibility create strong legal and organizational pressure to keep human judgment in final decisions.
Adoption barriers	claude-sonnet-5	4/5	Regulatory audits often require accountable, qualified personnel to respond to auditors and sign off on compliance matters, creating strong organizational and regulatory barriers to full automation.
Cost vs. human wage	claude-haiku-4-5-20251001	4/5	AI document review and preliminary audit preparation cost a fraction of a regulatory affairs specialist's hourly rate ($60–120/hr loaded). Amortized over many audit cycles, AI-assisted processes can reduce per-audit cost by 40–60%, though human oversight prevents full replacement economics.
Cost vs. human wage	claude-sonnet-5	2/5	Human specialists remain necessary for judgment calls and interfacing with auditors, so AI only reduces some prep costs rather than replacing the bulk of labor cost.
Technical feasibility today	claude-haiku-4-5-20251001	3/5	Several compliance and audit software platforms integrate AI for document review and anomaly detection (e.g., Workiva, Thomson Reuters EIKON), but most are narrow in scope and require human auditors for evidence interpretation, judgment calls, and sign-off. Production use exists but remains heavily human-supervised.
Technical feasibility today	claude-sonnet-5	2/5	AI tools exist for compiling records and flagging discrepancies but no deployed product independently conducts or represents an organization in audits reliably.

Prepare responses to customer requests for information, such as product data, written regulatory affairs statements, surveys, or questionnaires.

CI 43–54 · exposure 50 · augmentation 75 · importance 2.9/5 · click for rater detail

Panel ratings per dimension for this task
Dimension	Model	Rating	Rationale
Sector adoption velocity	claude-haiku-4-5-20251001	2/5	Regulatory affairs functions in pharma, biotech, and medical device sectors remain highly risk-averse and compliance-heavy; while early pilots exist, production deployment of AI-authored customer responses is still limited due to regulatory scrutiny and error-cost sensitivity.
Sector adoption velocity	claude-sonnet-5	3/5	Regulatory affairs sits within life sciences/pharma/med-device compliance functions, which are moderate adopters of AI tools for documentation but still cautious due to regulatory scrutiny and audit trails.
Augmentation potential	claude-haiku-4-5-20251001	4/5	AI is proving highly effective at drafting initial responses, compiling data sections, and structuring questionnaire answers, substantially accelerating the specialist's work while they focus on legal accuracy, policy alignment, and final sign-off.
Augmentation potential	claude-sonnet-5	4/5	AI substantially speeds up drafting, searching prior responses, and populating templates for customer/regulatory inquiries, meaningfully boosting specialist productivity while they retain final review and accountability.
Task automatability	claude-haiku-4-5-20251001	3/5	AI can draft responses to standard information requests and compile product data with reasonable accuracy, but responses to regulatory affairs questions typically require domain expertise, legal precision, and organizational policy alignment—elements that currently demand significant human review and editing to meet the 50% time-saving threshold reliably.
Task automatability	claude-sonnet-5	3/5	Drafting responses to standardized customer requests using existing product/regulatory data is well within LLM capability, but verifying accuracy against current regulatory status and compiling authoritative citations still requires human review, so only partial automation meets the equal-quality bar.
Adoption barriers	claude-haiku-4-5-20251001	4/5	Regulatory affairs responses often carry legal and compliance implications; many organizations require a licensed or credentialed specialist to sign off on or author statements to customers, and liability concerns create strong organizational and sometimes legal barriers to full automation.
Adoption barriers	claude-sonnet-5	3/5	No strict licensing requirement mandates only a certified specialist issue such responses, but liability for inaccurate regulatory statements and customer trust in specialist-signed communications create meaningful friction.
Cost vs. human wage	claude-haiku-4-5-20251001	4/5	AI inference and integration costs for generating these responses are substantially lower than the loaded cost of a regulatory specialist's time, especially for high-volume routine requests, though human review remains necessary.
Cost vs. human wage	claude-sonnet-5	3/5	AI can cheaply draft first-pass responses, but the need for regulatory specialist verification and sign-off adds substantial human cost, keeping the all-in cost closer to comparable than dramatically cheaper.
Technical feasibility today	claude-haiku-4-5-20251001	3/5	LLMs can generate competent draft responses to information requests and survey questionnaires in production settings, but deployed products still struggle with regulatory accuracy, consistency with company policy, and liability-sensitive statements, requiring material human oversight.
Technical feasibility today	claude-sonnet-5	3/5	Generative AI drafting tools and RAG-based document assembly are deployed in regulatory/compliance functions, but most organizations still require specialist review before responses go out due to accuracy and liability concerns.

Write or update standard operating procedures, work instructions, or policies.

CI 45–50 · exposure 50 · augmentation 75 · importance 3.5/5 · click for rater detail

Panel ratings per dimension for this task
Dimension	Model	Rating	Rationale
Sector adoption velocity	claude-haiku-4-5-20251001	3/5	Regulated industries (pharma, medical devices, finance) are piloting AI-assisted document generation, but full automation remains cautious; pilots are common but production deployment with minimal human oversight is rare due to compliance risk aversion.
Sector adoption velocity	claude-sonnet-5	3/5	Regulatory affairs functions in pharma, biotech, and med-tech are piloting AI-assisted documentation tools, but adoption is cautious and validation-heavy due to compliance stakes, placing it in the middle range.
Augmentation potential	claude-haiku-4-5-20251001	4/5	AI drafting tools substantially assist regulatory specialists by rapidly generating first drafts, organizing requirements, and identifying gaps in existing procedures, allowing experts to focus on compliance validation and strategic refinement rather than manual writing.
Augmentation potential	claude-sonnet-5	4/5	AI is highly useful for drafting boilerplate structure, standardizing language, and updating existing procedures based on redlines or regulatory changes, meaningfully speeding up the specialist's workflow while they retain final authority.
Task automatability	claude-haiku-4-5-20251001	3/5	AI can draft and update procedural documents by extracting requirements, organizing structure, and generating initial text, typically saving 40–60% of drafting time. However, ensuring regulatory compliance, organizational-specific context, and legal validation require substantial human oversight, preventing full end-to-end automation.
Task automatability	claude-sonnet-5	3/5	AI can draft or update SOPs and work instructions given templates and source material, saving significant drafting time, but ensuring regulatory accuracy, internal consistency, and organization-specific compliance nuances still requires substantial human review, capping full end-to-end automation.
Adoption barriers	claude-haiku-4-5-20251001	4/5	Regulatory affairs operates under strict compliance frameworks and audit requirements; organizations typically require human sign-off and accountability for SOPs and policies, and liability concerns for automated policy creation create strong organizational and legal barriers to full substitution.
Adoption barriers	claude-sonnet-5	3/5	While no law mandates a human author SOPs, regulated industries (pharma, medical devices, food) require documented review/approval by qualified personnel, and liability for inaccurate procedures creates meaningful oversight friction.
Cost vs. human wage	claude-haiku-4-5-20251001	3/5	AI inference and integration for document generation costs are comparable to the loaded labor cost of a regulatory specialist for routine updates, but specialized compliance reviews and legal sign-off still require human time, keeping overall cost ratios near parity.
Cost vs. human wage	claude-sonnet-5	3/5	AI drafting reduces time spent on initial document creation, but the need for expert review, regulatory cross-checking, and version control oversight keeps total cost only moderately below fully human-authored documents.
Technical feasibility today	claude-haiku-4-5-20251001	3/5	AI writing and document-generation tools are widely deployed and can produce coherent SOPs and policies, but they require material human review for accuracy, compliance fit, and domain-specific details. Products exist in production but with notable error rates in regulatory detail that necessitate subject-matter expert validation.
Technical feasibility today	claude-sonnet-5	3/5	Generative AI tools and enterprise document assistants are used today to draft and revise SOPs, but production use in regulated environments typically requires human validation against current regulations and internal quality systems, limiting reliability at scale.

Provide technical review of data or reports to be incorporated into regulatory submissions to assure scientific rigor, accuracy, and clarity of presentation.

CI 28–66 · exposure 50 · augmentation 88 · importance 4.2/5 · click for rater detail

Panel ratings per dimension for this task
Dimension	Model	Rating	Rationale
Sector adoption velocity	claude-haiku-4-5-20251001	3/5	Pharma and biotech firms are piloting AI-assisted compliance review, but adoption remains concentrated in large organizations with high regulatory volume. Smaller firms and agencies lag; production deployment is still emerging rather than normalized across the sector.
Sector adoption velocity	claude-sonnet-5	3/5	Pharma/biotech and regulatory affairs functions are increasingly piloting AI tools for document review and drafting assistance, but full production-scale reliance on AI for critical technical review is still limited by compliance caution.
Augmentation potential	claude-haiku-4-5-20251001	5/5	AI dramatically augments regulatory specialists by handling data extraction, cross-checking against standards, flagging inconsistencies, and generating structured review checklists, freeing the specialist to focus on scientific judgment and submission strategy. This is a textbook assistive-AI use case where the human remains accountable and in control.
Augmentation potential	claude-sonnet-5	4/5	AI tools significantly speed up drafting, consistency checking, and data summarization, allowing specialists to focus more on judgment-intensive review, meaningfully boosting productivity while humans remain accountable.
Task automatability	claude-haiku-4-5-20251001	4/5	Current AI systems can reliably extract data from reports, validate scientific rigor against established criteria, flag inconsistencies, check formatting compliance, and generate detailed review summaries with >50% time savings. However, nuanced judgments about novel experimental designs or emerging scientific standards still benefit from human validation, preventing a full 5 rating.
Task automatability	claude-sonnet-5	2/5	AI can assist in flagging inconsistencies, checking formatting, and summarizing data, but the core judgment of scientific rigor and regulatory acceptability requires domain expertise and accountability that current AI cannot fully replicate end-to-end.
Adoption barriers	claude-haiku-4-5-20251001	4/5	Regulatory affairs is legally high-stakes: human sign-off is typically required on final submissions, and liability for errors in regulatory filings creates organizational friction and audit trails. However, AI-assisted review (not full automation) is increasingly acceptable to regulators, so the barrier is material but not absolute.
Adoption barriers	claude-sonnet-5	4/5	Regulatory submissions typically require sign-off by qualified, often credentialed regulatory affairs professionals, and errors carry major liability and compliance risk, creating strong barriers to full automation.
Cost vs. human wage	claude-haiku-4-5-20251001	5/5	AI inference, integration into document pipelines, and light human oversight are orders of magnitude cheaper than the fully loaded cost of a regulatory specialist reviewing lengthy reports and datasets. Automation can process volumes at pennies per report versus hundreds of dollars per human review.
Cost vs. human wage	claude-sonnet-5	2/5	AI can reduce time on initial screening and drafting checks, but human expert review remains necessary for liability and accuracy, keeping blended costs closer to comparable rather than order-of-magnitude cheaper.
Technical feasibility today	claude-haiku-4-5-20251001	4/5	Mature products (document AI, compliance software, LLM-based review tools) are deployed in regulated industries and can perform data extraction, consistency checking, and standards-based validation reliably. Some healthcare and pharma organizations use AI-assisted review pipelines in production, though most workflows retain human sign-off, preventing a perfect 5.
Technical feasibility today	claude-sonnet-5	2/5	Some products (e.g., document QC tools, LLM-based reviewers) exist to assist with checking submissions, but no deployed product independently performs reliable technical review of scientific rigor for regulatory filings at scale.

Recommend changes to company procedures in response to changes in regulations or standards.

CI 25–62 · exposure 45 · augmentation 75 · importance 4.0/5 · click for rater detail

Panel ratings per dimension for this task
Dimension	Model	Rating	Rationale
Sector adoption velocity	claude-haiku-4-5-20251001	3/5	Professional services and regulated industries (pharma, finance, legal) are adopting AI-powered regulatory tracking and analysis, but adoption is still in the pilot-and-early-production phase rather than mature, widespread deployment across all sectors.
Sector adoption velocity	claude-sonnet-5	2/5	Highly regulated industries (pharma, finance, medical devices) tend to be cautious adopters of AI for compliance-critical judgment tasks, with pilots more common than full production deployment.
Augmentation potential	claude-haiku-4-5-20251001	4/5	AI significantly augments specialists' productivity by automating regulatory scanning, identifying relevant changes, and drafting preliminary recommendations, leaving the expert to focus on judgment, strategy, and organizational fit rather than basic research and document review.
Augmentation potential	claude-sonnet-5	4/5	AI can efficiently scan and summarize regulatory updates, compare them against existing procedures, and draft initial recommendations, substantially speeding up the specialist's research and drafting phase.
Task automatability	claude-haiku-4-5-20251001	4/5	AI can analyze regulatory changes, cross-reference company procedures, identify gaps, and generate recommendations with minimal human intervention, meeting the ≥50% time-saving threshold. However, the task may require domain expertise and judgment calls that warrant human review, preventing a full 5.
Task automatability	claude-sonnet-5	2/5	AI can help summarize regulatory changes and draft possible procedural updates, but synthesizing organizational context, risk tolerance, and judgment-based recommendations requires human expertise beyond current end-to-end automation.
Adoption barriers	claude-haiku-4-5-20251001	3/5	While there is no legal requirement that a human must sign off, organizational and liability concerns mean most companies retain regulatory specialists to validate AI recommendations. Compliance oversight and error accountability create meaningful friction to full replacement.
Adoption barriers	claude-sonnet-5	4/5	Regulatory affairs decisions often require sign-off from qualified professionals, carry legal/compliance liability, and are subject to audit and regulatory scrutiny, creating strong organizational and legal barriers to full automation.
Cost vs. human wage	claude-haiku-4-5-20251001	4/5	AI-powered regulatory monitoring and recommendation generation costs (subscription to services + LLM inference) are substantially lower than the salary of a specialist reviewing changes manually, likely 3–10× cheaper all-in when integrated with existing workflows.
Cost vs. human wage	claude-sonnet-5	2/5	AI tools reduce research time but still require significant human review, validation against company-specific context, and liability sign-off, keeping total cost closer to human-comparable levels.
Technical feasibility today	claude-haiku-4-5-20251001	3/5	Deployed AI tools (document analysis, regulatory tracking systems with LLM backends) can assist with this task but currently perform with variable accuracy on complex regulatory interpretation and require human oversight. Mature end-to-end automation is not yet standard in production across industries.
Technical feasibility today	claude-sonnet-5	2/5	Some regulatory intelligence and compliance software products flag regulatory changes and suggest generic updates, but no deployed product reliably generates company-specific procedural recommendations at production quality.

Maintain current knowledge base of existing and emerging regulations, standards, or guidance documents.

CI 30–55 · exposure 42 · augmentation 88 · importance 4.0/5 · click for rater detail

Panel ratings per dimension for this task
Dimension	Model	Rating	Rationale
Sector adoption velocity	claude-haiku-4-5-20251001	2/5	Adoption is slow: pharmaceutical, medical device, and financial services firms use monitoring tools but retain specialists for interpretation and decision-making. Most organizations have not displaced specialists; tools are assistive, not substitutive. Regulatory conservatism limits fast experimentation.
Sector adoption velocity	claude-sonnet-5	3/5	Regulated industries (pharma, finance, medical devices) are moderately fast adopters of compliance-tech and RegTech tools, though full reliance on AI without human verification remains limited.
Augmentation potential	claude-haiku-4-5-20251001	4/5	AI excels at augmenting this task: automated monitoring of regulatory databases, rapid summarization of lengthy guidance documents, and alerting specialists to emerging rules significantly amplify their coverage and response speed. Specialists remain in control and leverage AI for scaling their attention.
Augmentation potential	claude-sonnet-5	5/5	AI substantially augments this task by continuously scanning, summarizing, and alerting to regulatory changes, letting specialists focus on interpretation and application rather than manual searching.
Task automatability	claude-haiku-4-5-20251001	2/5	AI can assist with monitoring regulatory sources and summarizing new documents, but cannot independently assess materiality, judge legal implications, or contextualize regulations relative to specific organizational risk—tasks requiring expert judgment and accountability that regulatory specialists perform. Time savings would be modest.
Task automatability	claude-sonnet-5	3/5	AI can continuously monitor, summarize, and flag regulatory changes from published sources, saving significant research time, but validating relevance, jurisdictional nuance, and applicability still requires human expertise.
Adoption barriers	claude-haiku-4-5-20251001	4/5	Regulatory affairs specialists maintain institutional knowledge tied to compliance sign-off and legal defensibility; errors carry liability and reputational cost. Regulatory bodies often expect human expertise and accountability in compliance files. Organizational and professional norms strongly favor human continuity in this role.
Adoption barriers	claude-sonnet-5	2/5	No licensing requirement for monitoring regulations itself, though downstream reliance on this knowledge for compliance decisions creates some liability-driven caution about fully trusting automated feeds.
Cost vs. human wage	claude-haiku-4-5-20251001	2/5	Regulatory intelligence platforms and AI tooling carry substantial per-seat licensing costs and integration overhead. When factored against the senior expertise required to validate and act on AI-generated summaries, the cost advantage over a specialist's time is marginal to negative.
Cost vs. human wage	claude-sonnet-5	3/5	Subscription-based AI regulatory tracking tools are cheaper than dedicated staff hours for scanning, but ongoing curation, verification, and subscription costs keep the ratio only moderately favorable.
Technical feasibility today	claude-haiku-4-5-20251001	3/5	Deployed tools can monitor regulatory feeds, summarize documents, and flag changes with reasonable accuracy, but production systems often miss nuanced developments, struggle with ambiguous guidance, and require significant human review. Commercial regulatory intelligence platforms exist but are narrow in scope.
Technical feasibility today	claude-sonnet-5	3/5	Regulatory intelligence and horizon-scanning tools exist and are used in pharma, finance, and other regulated industries, but they still require human review to avoid missed nuance or false negatives.

Review adverse drug reactions and file all related reports in accordance with regulatory agency guidelines.

CI 39–45 · exposure 50 · augmentation 75 · importance 4.3/5 · click for rater detail

Panel ratings per dimension for this task
Dimension	Model	Rating	Rationale
Sector adoption velocity	claude-haiku-4-5-20251001	2/5	Pharma and biotech are moderately digitized but highly risk-averse on safety-critical processes; adoption of AI-assisted tools is slow and conservative, with most organizations still in pilot or limited integration phases rather than production-scale deployment of autonomous systems.
Sector adoption velocity	claude-sonnet-5	3/5	Pharmacovigilance and regulatory affairs functions in pharma are adopting AI-assisted case processing and coding tools at a moderate pace, with pilots widespread but full-scale autonomous deployment still limited.
Augmentation potential	claude-haiku-4-5-20251001	4/5	AI excels at surfacing patterns in adverse event databases, flagging duplicates, and accelerating report template population, substantially boosting specialist productivity while preserving expert judgment on medical assessment and regulatory decisions.
Augmentation potential	claude-sonnet-5	4/5	AI significantly speeds up case intake, coding, duplicate checking, and narrative drafting, meaningfully boosting specialist throughput while humans retain final review and filing responsibility.
Task automatability	claude-haiku-4-5-20251001	3/5	AI can extract and classify adverse events from unstructured data and generate report templates with significant time savings, but human judgment on causality assessment, medical interpretation, and regulatory nuance typically requires expert review, preventing full end-to-end automation at equal quality.
Task automatability	claude-sonnet-5	3/5	AI can extract, categorize, and draft structured adverse event reports (e.g., MedDRA coding, narrative drafting) from source data, but causality assessment and final regulatory judgment calls typically still require human review, so only partial time savings are achievable end-to-end.
Adoption barriers	claude-haiku-4-5-20251001	4/5	FDA, EMA, and other regulators require documented accountability for adverse event reports and causality assessments; pharmacovigilance specialists must sign off on report accuracy and medical interpretation, creating legal and liability barriers to full automation.
Adoption barriers	claude-sonnet-5	4/5	Regulatory agencies (FDA, EMA) require qualified personnel to review and attest to adverse event reports, and submissions carry significant liability, creating strong sign-off and compliance barriers to full automation.
Cost vs. human wage	claude-haiku-4-5-20251001	2/5	While AI tools reduce data entry and initial triage labor, regulatory compliance demands expert pharmacovigilance review, oversight integration, and quality assurance that keep overall costs comparable to or higher than traditional human workflow for mission-critical adverse event reporting.
Cost vs. human wage	claude-sonnet-5	3/5	AI tools reduce case processing time substantially, but licensing, validation, and mandatory human oversight for regulatory submissions keep blended costs only moderately below fully manual processing rather than an order of magnitude cheaper.
Technical feasibility today	claude-haiku-4-5-20251001	3/5	NLP and extraction tools exist and are used in some pharma workflows, but deployed systems still have material error rates in event classification and miss contextual safety signals, requiring substantial human oversight rather than reliable autonomous operation.
Technical feasibility today	claude-sonnet-5	3/5	Pharmacovigilance software with NLP-based case triage, coding suggestions, and duplicate detection is deployed in production at many pharma companies, but fully autonomous filing without human QC is not standard practice due to error and compliance risk.

Recommend adjudication of product complaints.

CI 25–55 · exposure 45 · augmentation 75 · importance 3.2/5 · click for rater detail

Panel ratings per dimension for this task
Dimension	Model	Rating	Rationale
Sector adoption velocity	claude-haiku-4-5-20251001	2/5	While pharma and medical device firms are piloting AI-assisted complaint triage, actual production adoption of AI-driven adjudication recommendations remains limited due to regulatory conservatism, liability concerns, and the need for human accountability in formal complaint handling.
Sector adoption velocity	claude-sonnet-5	2/5	Regulatory affairs in pharma/medical device sectors adopts AI cautiously due to compliance risk, with pilots for document review but adjudication decisions remain human-led.
Augmentation potential	claude-haiku-4-5-20251001	4/5	AI assistants meaningfully boost specialist productivity by auto-summarizing complaints, flagging relevant regulations, surfacing similar precedents, and drafting initial assessments, allowing the human to focus on judgment calls and risk assessment rather than data gathering and document review.
Augmentation potential	claude-sonnet-5	4/5	AI can meaningfully assist by retrieving similar complaint histories, summarizing regulations, and drafting rationale, significantly speeding up the specialist's analysis while they retain final judgment.
Task automatability	claude-haiku-4-5-20251001	4/5	AI systems can analyze complaint data, extract relevant regulatory frameworks, and generate evidence-based recommendations with >50% time savings. However, final adjudication often requires human judgment on precedent, nuance, and organizational risk tolerance, preventing full end-to-end automation without human review.
Task automatability	claude-sonnet-5	2/5	Adjudicating product complaints requires synthesizing regulatory knowledge, risk assessment, and judgment calls that AI can support but not reliably finalize end-to-end at equal quality yet.'
Adoption barriers	claude-haiku-4-5-20251001	4/5	Regulatory adjudication often involves legal accountability, documentation requirements for FDA/EMA submissions, and organizational liability for incorrect determinations. Many jurisdictions and companies mandate human sign-off by a licensed or qualified regulatory professional, creating material friction.
Adoption barriers	claude-sonnet-5	4/5	Regulatory affairs work is subject to compliance frameworks (e.g., FDA, ISO) requiring qualified personnel to sign off on complaint dispositions, creating strong liability and authorization barriers.
Cost vs. human wage	claude-haiku-4-5-20251001	4/5	AI systems (document analysis, classification, recommendation engines) cost substantially less per complaint processed than a fully-loaded regulatory affairs specialist, with inference and integration costs amortized across high complaint volumes in pharma, medical device, and consumer product sectors.
Cost vs. human wage	claude-sonnet-5	2/5	Given the need for extensive human oversight, verification against regulations, and liability review, AI-assisted adjudication is not yet dramatically cheaper than trained specialists performing this task.
Technical feasibility today	claude-haiku-4-5-20251001	3/5	Deployed AI systems can draft complaint analyses and flag regulatory issues reliably, but few production systems handle complete complaint adjudication workflows without material error rates or requiring significant manual oversight and refinement by regulatory specialists.
Technical feasibility today	claude-sonnet-5	2/5	AI tools can draft summaries or flag similar past cases, but no deployed product independently issues reliable complaint adjudication recommendations in regulated industries at scale today.

Develop or track quality metrics.

CI 30–48 · exposure 38 · augmentation 75 · importance 3.3/5 · click for rater detail

Panel ratings per dimension for this task
Dimension	Model	Rating	Rationale
Sector adoption velocity	claude-haiku-4-5-20251001	2/5	Pharma, biotech, and medical devices (where regulatory affairs is critical) remain relatively conservative in automation adoption. Metric tracking tools are deployed, but AI-driven metric development and autonomous adjustment remain rare in production. Adoption is slower than in pure software or finance sectors.
Sector adoption velocity	claude-sonnet-5	2/5	Regulatory affairs in life sciences/medical devices is a slower-adopting, compliance-heavy sector where AI tool integration into quality systems is still nascent and cautious.
Augmentation potential	claude-haiku-4-5-20251001	4/5	AI significantly assists specialists by automating routine metric calculation, surfacing anomalies, generating draft dashboards, and suggesting trending patterns. The human remains accountable for metric validity and regulatory interpretation, but productivity gains are substantial on the operational side of the task.
Augmentation potential	claude-sonnet-5	4/5	AI can meaningfully assist by automating data collection, trend analysis, and report drafting for quality metrics, letting specialists focus on interpretation and regulatory judgment.
Task automatability	claude-haiku-4-5-20251001	3/5	AI can automate parts of quality metric tracking (data aggregation, dashboard generation, anomaly detection) but developing new metrics requires domain judgment and business alignment. Setup overhead and human verification for metric definitions limits time savings to roughly 40-50% on the full workflow.
Task automatability	claude-sonnet-5	2/5	Developing meaningful quality metrics requires domain judgment about regulatory risk and organizational context that current AI cannot independently determine; tracking/aggregating data can be partially automated, but the full task is not yet at the 50% time-saving bar end-to-end.
Adoption barriers	claude-haiku-4-5-20251001	3/5	Regulatory frameworks often require documented human oversight and sign-off on quality metrics that feed compliance decisions. Organizations also show resistance to algorithm-driven metric changes without expert review. These create moderate friction but not hard legal prohibitions on automation itself.
Adoption barriers	claude-sonnet-5	3/5	No strict licensing requirement mandates a human for this specific task, but organizational quality systems (e.g., ISO, FDA QMS) often require documented human accountability and sign-off on metrics used for compliance decisions.
Cost vs. human wage	claude-haiku-4-5-20251001	3/5	Cloud-based analytics platforms with AI features cost $100–500/month plus integration labor; a regulatory specialist's loaded cost is ~$75–150/hour. For tracking mature metrics, AI becomes cost-advantageous; for developing novel ones, human time dominates. Overall roughly comparable when accounting for full spectrum of the task.
Cost vs. human wage	claude-sonnet-5	2/5	Data aggregation tools are cheap, but the metric design and regulatory interpretation still require skilled human labor, so overall cost savings versus a human specialist are modest.
Technical feasibility today	claude-haiku-4-5-20251001	3/5	Products exist for automated data collection, visualization, and basic anomaly flagging (Tableau, Power BI, specialized monitoring tools with AI), but defining appropriate metrics and interpreting them in regulatory context still requires human expertise. Tools work reliably on tracking once metrics are established, but metric development remains a research-assisted rather than fully deployed capability.
Technical feasibility today	claude-sonnet-5	2/5	Dashboarding and analytics tools exist and are widely deployed for tracking, but no product reliably develops appropriate quality metrics for regulatory affairs without substantial human design and validation.

Provide pre-, ongoing, and post-inspection follow-up assistance to governmental inspectors.

CI 20–55 · exposure 41 · augmentation 88 · importance 4.0/5 · click for rater detail

Panel ratings per dimension for this task
Dimension	Model	Rating	Rationale
Sector adoption velocity	claude-haiku-4-5-20251001	2/5	Regulatory affairs remains dominated by large pharma, biotech, and heavily regulated industries with slower digital maturity than tech or finance. Adoption of AI agents in inspection follow-up is nascent; most firms still rely on manual specialist workflows and incremental compliance software rather than end-to-end automation.
Sector adoption velocity	claude-sonnet-5	2/5	Regulatory affairs in regulated industries (pharma, medical devices, food) adopts AI cautiously and slowly given compliance risk and audit trail requirements.
Augmentation potential	claude-haiku-4-5-20251001	5/5	AI substantially augments specialist productivity by automating evidence gathering, regulatory mapping, document drafting, and timeline tracking—allowing specialists to focus on judgment-heavy negotiation, exception-handling, and strategic compliance guidance. The human expert remains central and AI acts as a force-multiplier.
Augmentation potential	claude-sonnet-5	4/5	AI can meaningfully assist by organizing inspection records, drafting responses, tracking action items, and flagging compliance gaps before/after inspections.
Task automatability	claude-haiku-4-5-20251001	4/5	AI can substantially automate documentation preparation, compliance checklist generation, inspection scheduling coordination, and follow-up communication—activities that account for a large portion of the workload and can easily achieve 50% time savings. The human-facing aspects of direct inspector interaction remain necessary, but most administrative and logistical burden is automatable.
Task automatability	claude-sonnet-5	2/5	This task involves coordinating with inspectors, preparing documentation, and responding to real-time findings, requiring judgment, negotiation, and physical/organizational presence that current AI cannot substitute end-to-end.'
Adoption barriers	claude-haiku-4-5-20251001	4/5	Governmental inspection processes operate under formal regulatory frameworks where human inspectors retain legal authority and sign-off requirements; many jurisdictions mandate direct human specialist involvement in pre- and post-inspection coordination. Liability, regulatory precedent, and inspection-chain-of-custody rules create material adoption friction.
Adoption barriers	claude-sonnet-5	4/5	Regulatory affairs work often requires named, accountable personnel interacting with government inspectors, with liability and compliance obligations that discourage full automation.
Cost vs. human wage	claude-haiku-4-5-20251001	4/5	AI-driven compliance automation and document generation cost substantially less than specialist labor (inference + data retrieval is low-cost compared to hourly rates), though integration with inspection workflows and oversight oversight introduces moderate friction. The cost advantage is significant but not yet an order of magnitude.
Cost vs. human wage	claude-sonnet-5	2/5	AI can cut document prep time but the core interpersonal liaison work still requires a paid human specialist, so overall cost savings are modest.
Technical feasibility today	claude-haiku-4-5-20251001	3/5	Products exist for compliance document generation, inspection tracking systems, and regulatory alert services, but they operate with material limitations in handling context-specific regulatory nuance and edge cases. Deployed systems are reliable for routine tasks but require human oversight for novel or complex situations.
Technical feasibility today	claude-sonnet-5	1/5	No deployed product manages inspector liaison and follow-up assistance in production; this remains a human relationship-management and compliance function.

Prepare or maintain technical files as necessary to obtain and sustain product approval.

CI 25–37 · exposure 33 · augmentation 63 · importance 4.5/5 · click for rater detail

Panel ratings per dimension for this task
Dimension	Model	Rating	Rationale
Sector adoption velocity	claude-haiku-4-5-20251001	2/5	Regulatory affairs organizations remain cautious with AI adoption in this core function; while AI-powered document tools are emerging, actual production adoption for autonomous technical file preparation is limited, and risk-averse pharma and medical device sectors favor incremental, human-centered augmentation over displacement.
Sector adoption velocity	claude-sonnet-5	2/5	Regulated industries (medical devices, pharma) are typically slow to adopt AI for compliance-critical documentation due to audit and liability concerns, though pilot tools are emerging.
Augmentation potential	claude-haiku-4-5-20251001	3/5	AI can meaningfully assist with document drafting, compliance cross-checking against known regulatory requirements, and boilerplate generation, raising specialist productivity on routine file components, though the human must verify all outputs for accuracy and regulatory sufficiency.
Augmentation potential	claude-sonnet-5	4/5	AI substantially helps by drafting sections, tracking version changes, checking regulatory requirements, and flagging missing data, meaningfully speeding up the specialist's workflow.
Task automatability	claude-haiku-4-5-20251001	2/5	While AI can assist with document compilation, formatting, and some boilerplate content generation, the task requires complex regulatory judgment, cross-referencing evolving regulations, and maintaining legal accuracy that current AI systems cannot reliably do end-to-end without substantial human oversight and correction.
Task automatability	claude-sonnet-5	3/5	AI can draft, organize, and cross-reference technical file sections (e.g., compiling test data, summarizing standards compliance) but final assembly requires domain judgment, verification of accuracy, and accountability that current tools cannot fully replace.asse
Adoption barriers	claude-haiku-4-5-20251001	4/5	Strong regulatory and liability barriers exist: regulatory bodies require human accountability and signature authority, legal liability for false or incomplete technical files falls on the organization and the responsible person, and many jurisdictions mandate a licensed expert's attestation.
Adoption barriers	claude-sonnet-5	4/5	Regulatory submissions (e.g., FDA, EU MDR) often require qualified persons to attest to accuracy and completeness, creating strong liability and compliance barriers to full automation.
Cost vs. human wage	claude-haiku-4-5-20251001	2/5	AI-assisted tools (LLMs, document automation) reduce some clerical work, but the cost of errors in regulatory submissions is extremely high, and human specialist oversight remains mandatory, making the all-in cost still substantially below full human replacement.
Cost vs. human wage	claude-sonnet-5	3/5	AI can reduce drafting and formatting time substantially, but human regulatory specialists must still review, validate, and take liability, so total cost savings are moderate rather than order-of-magnitude.
Technical feasibility today	claude-haiku-4-5-20251001	2/5	No deployed product reliably handles the full technical file preparation task; existing AI tools can help with draft generation and document organization, but regulatory specialists report significant manual review, revision, and domain expertise needed to meet submission standards.
Technical feasibility today	claude-sonnet-5	2/5	Some regulatory-tech products assist with document generation, gap analysis, and template population, but no mature product autonomously prepares and maintains full technical files reliably across product types and jurisdictions in production.

Interpret regulatory rules or rule changes and ensure that they are communicated through corporate policies and procedures.

CI 25–32 · exposure 30 · augmentation 75 · importance 4.4/5 · click for rater detail

Panel ratings per dimension for this task
Dimension	Model	Rating	Rationale
Sector adoption velocity	claude-haiku-4-5-20251001	2/5	Regulatory and compliance sectors tend to be risk-averse and slower to adopt automation for mission-critical tasks; most organizations remain in pilot or assistive-tool phase rather than full deployment.
Sector adoption velocity	claude-sonnet-5	3/5	Compliance and regulatory affairs functions in finance, pharma, and professional services are adopting AI tools for monitoring and drafting, but production-level reliance remains in pilot or augmented stages.
Augmentation potential	claude-haiku-4-5-20251001	4/5	AI can significantly assist by rapidly summarizing regulatory changes, flagging relevant sections, and drafting initial policy language, allowing specialists to focus on interpretation and strategy rather than manual document review.
Augmentation potential	claude-sonnet-5	4/5	AI significantly aids in tracking rule changes, summarizing lengthy regulations, and drafting initial policy language, substantially speeding up the specialist's workflow while they retain final judgment.
Task automatability	claude-haiku-4-5-20251001	2/5	AI can summarize rule changes and draft policy language, but interpreting regulatory nuance, assessing corporate-specific implications, and ensuring compliance strategy requires human judgment. End-to-end automation with 50% time savings at equal quality is not yet achieved.
Task automatability	claude-sonnet-5	2/5	AI can help summarize and flag regulatory changes but interpreting their business implications and translating them into enforceable corporate policy requires contextual judgment and accountability beyond current AI capability at equal quality end-to-end.
Adoption barriers	claude-haiku-4-5-20251001	4/5	Regulatory interpretation often requires licensed professionals (e.g., in pharmaceuticals, securities) and carries high error-cost asymmetry—misinterpretation can trigger fines or legal liability. Organizational accountability typically requires human sign-off.
Adoption barriers	claude-sonnet-5	4/5	Regulatory interpretation often requires sign-off by qualified professionals given liability exposure for non-compliance, creating strong organizational and legal barriers to full automation.
Cost vs. human wage	claude-haiku-4-5-20251001	2/5	AI inference is cheap, but the specialized regulatory knowledge, oversight, and potential liability mean total cost of ownership remains comparable to or higher than a skilled regulatory affairs specialist.
Cost vs. human wage	claude-sonnet-5	2/5	AI tools reduce research time but still require substantial human review and integration effort, so all-in cost savings versus a skilled specialist are moderate, not dramatic.
Technical feasibility today	claude-haiku-4-5-20251001	3/5	AI tools can assist with document analysis and policy drafting, but no deployed product reliably handles the full scope of regulatory interpretation and organizational policy integration without material human review and correction.
Technical feasibility today	claude-sonnet-5	2/5	Products exist for regulatory monitoring and summarization (e.g., compliance software with NLP), but reliable interpretation and policy drafting in production with low error rates is not yet standard practice.

Determine regulations or procedures related to the management, collection, reuse, recovery, or recycling of packaging waste.

CI 25–32 · exposure 25 · augmentation 75 · importance 2.3/5 · click for rater detail

Panel ratings per dimension for this task
Dimension	Model	Rating	Rationale
Sector adoption velocity	claude-haiku-4-5-20251001	2/5	Regulatory and compliance functions remain relatively risk-averse and slow to adopt autonomous AI. Most adoption to date involves AI-assisted research tools rather than autonomous determination, and actual deployment of agents for regulatory decision-making is still limited and piloted rather than mainstream.
Sector adoption velocity	claude-sonnet-5	3/5	Regulatory/compliance functions in manufacturing and consumer goods sectors are adopting AI-assisted research tools at a moderate pace, with pilots more common than full production reliance for compliance determinations.
Augmentation potential	claude-haiku-4-5-20251001	4/5	AI can meaningfully assist regulatory specialists by rapidly surfacing relevant regulations, summarizing requirements, and flagging jurisdictional variations, allowing the human expert to focus on interpretation and applicability judgment. Large language models and search tools already enhance productivity in regulatory research without replacing the specialist's role.
Augmentation potential	claude-sonnet-5	4/5	AI substantially speeds up locating, summarizing, and cross-referencing regulations across jurisdictions, meaningfully boosting specialist productivity even though final determinations remain human-led.
Task automatability	claude-haiku-4-5-20251001	2/5	AI can retrieve and summarize existing regulations and procedures from structured databases or documents, but determining relevant regulations for specific contexts requires nuanced judgment about applicability, jurisdiction, and integration with organizational practices. Current systems struggle with the interpretive and contextual reasoning needed for reliable regulatory determination.
Task automatability	claude-sonnet-5	2/5	AI can retrieve and summarize regulatory text about packaging waste but determining applicable regulations requires judgment about jurisdiction, product classification, and evolving compliance obligations that current systems cannot reliably finalize end-to-end.
Adoption barriers	claude-haiku-4-5-20251001	4/5	Regulatory determinations carry legal and compliance risk; organizations typically require a licensed or credentialed regulatory affairs professional to own or sign off on such decisions. Liability asymmetry (errors in regulation interpretation can result in significant penalties) and organizational risk management practices create strong barriers to full automation.
Adoption barriers	claude-sonnet-5	3/5	While not strictly requiring a licensed professional in all jurisdictions, regulatory determinations often carry liability exposure and organizational sign-off requirements that create meaningful friction against pure automation.
Cost vs. human wage	claude-haiku-4-5-20251001	2/5	Current AI research and compliance tools require substantial integration, human oversight, and validation by regulatory specialists to ensure accuracy. The all-in cost of AI-assisted research often exceeds the time saved compared to a human specialist conducting targeted research, especially given liability sensitivity.
Cost vs. human wage	claude-sonnet-5	2/5	AI tools can cut research time but the need for expert verification, licensing of regulatory databases, and liability review keeps costs closer to comparable rather than dramatically cheaper.
Technical feasibility today	claude-haiku-4-5-20251001	2/5	While AI tools can search regulatory databases and extract text, no mature product reliably determines which specific regulations apply to a given situation without significant human verification. Regulatory research assistants exist but typically require expert review and cannot independently make determinations that legal or compliance teams would trust.
Technical feasibility today	claude-sonnet-5	2/5	Legal/regulatory research assistants and compliance software exist and can surface relevant rules, but no deployed product reliably performs authoritative determination of applicable packaging waste regulations without expert review.

Develop or conduct employee regulatory training.

CI 25–30 · exposure 25 · augmentation 63 · importance 3.2/5 · click for rater detail

Panel ratings per dimension for this task
Dimension	Model	Rating	Rationale
Sector adoption velocity	claude-haiku-4-5-20251001	2/5	Regulatory affairs is a compliance-heavy, risk-averse sector with slower AI adoption. Organizations in this space prioritize legal defensibility and human accountability over efficiency gains, limiting real-world deployment of AI-driven training solutions beyond pilot stages.
Sector adoption velocity	claude-sonnet-5	2/5	Regulatory affairs functions are cautious adopters of AI due to compliance risk, though generative AI tools for drafting training content are beginning to see pilot use.
Augmentation potential	claude-haiku-4-5-20251001	3/5	AI can usefully assist regulatory specialists by drafting training outlines, generating scenario-based examples, and organizing regulatory updates; however, the human specialist must validate accuracy and legal applicability, moderating the productivity boost relative to fully automated alternatives.
Augmentation potential	claude-sonnet-5	4/5	AI is quite useful for drafting training materials, generating quizzes, summarizing regulations, and creating first-pass content that specialists then refine and deliver.
Task automatability	claude-haiku-4-5-20251001	2/5	While AI can generate training content and draft materials, end-to-end development and delivery of compliant employee regulatory training requires human judgment on organizational context, legal nuance, and tailored compliance messaging. Current systems struggle with the full cycle of needs assessment, customization, and assessment without significant human oversight.
Task automatability	claude-sonnet-5	2/5	AI can help draft training materials and content outlines, but designing and conducting effective employee regulatory training requires tailoring to organizational context, interactive delivery, and Q&A handling that current systems cannot fully replace end-to-end.
Adoption barriers	claude-haiku-4-5-20251001	4/5	Regulatory training often has compliance and liability requirements; companies must document that training meets legal standards, and human oversight of content accuracy is typically mandatory. Liability for inadequate training falls on the organization, creating strong incentives to retain human regulatory expertise in the development and sign-off process.
Adoption barriers	claude-sonnet-5	3/5	Many regulated industries require documented, verifiable training with human accountability for content accuracy and sign-off, creating moderate compliance and liability barriers to full automation.
Cost vs. human wage	claude-haiku-4-5-20251001	2/5	While AI tools reduce content creation costs, the required human legal review, customization, and oversight of training delivery mean the total cost remains comparable to or higher than human-led training development in regulated contexts.
Cost vs. human wage	claude-sonnet-5	2/5	AI can cheaply generate draft content, but the full task including SME review, compliance validation, and live/interactive delivery still requires significant human cost, keeping overall savings modest.
Technical feasibility today	claude-haiku-4-5-20251001	2/5	AI can assist with content generation and deliver parts of training modules, but no production system reliably handles the full regulatory training lifecycle (from regulatory intelligence to employee comprehension assessment) without material human intervention and legal review.
Technical feasibility today	claude-sonnet-5	2/5	AI writing tools and e-learning content generators exist and are used to draft training materials, but no deployed product reliably conducts full regulatory training programs including delivery, assessment, and compliance documentation.

Coordinate efforts associated with the preparation of regulatory documents or submissions.

CI 25–28 · exposure 25 · augmentation 75 · importance 4.6/5 · click for rater detail

Panel ratings per dimension for this task
Dimension	Model	Rating	Rationale
Sector adoption velocity	claude-haiku-4-5-20251001	3/5	Pharma and device companies are piloting AI-assisted document drafting, but production adoption of AI coordination tools remains limited. Most organizations still use humans for orchestration, with AI serving as a drafting aid rather than autonomous coordinator.
Sector adoption velocity	claude-sonnet-5	2/5	Regulated industries like pharma and medical devices are typically cautious adopters of AI for compliance-critical workflows, with pilots emerging but production-scale coordination automation still rare.
Augmentation potential	claude-haiku-4-5-20251001	4/5	AI excels at augmenting regulatory specialists by auto-generating first drafts, cross-referencing requirements, flagging inconsistencies, and organizing submissions—all of which raise specialist productivity significantly while the human remains in control of strategy and final accountability.
Augmentation potential	claude-sonnet-5	4/5	AI tools can significantly speed up drafting, formatting, cross-referencing regulations, and tracking submission status, meaningfully augmenting a specialist's coordination work.
Task automatability	claude-haiku-4-5-20251001	2/5	While AI can assist with drafting and organizing regulatory documents, the task requires substantive coordination of multi-stakeholder efforts, prioritization of competing requirements, and judgment calls on regulatory strategy that remain fundamentally human. AI tools can generate templates and compile information, but orchestrating end-to-end document preparation with <50% time savings at equal quality is not yet achievable.
Task automatability	claude-sonnet-5	2/5	Coordination involves cross-functional communication, scheduling, judgment calls on priorities, and negotiation with stakeholders which current AI cannot fully replicate end-to-end, though drafting sub-tasks can be assisted.
Adoption barriers	claude-haiku-4-5-20251001	4/5	Regulatory submissions often require sign-off by licensed professionals (pharmacists, toxicologists, engineers) and carry material liability if inaccurate. Regulatory bodies may require human accountability for document content, and organizational risk aversion around compliance submissions creates strong friction against full automation.
Adoption barriers	claude-sonnet-5	4/5	Regulatory submissions (e.g., FDA, EMA) require accountable, often credentialed personnel to sign off, and errors carry high legal/compliance risk, creating strong barriers to full automation.
Cost vs. human wage	claude-haiku-4-5-20251001	2/5	AI-assisted drafting tools cost several thousand dollars annually and require human regulatory specialists to direct and review output. The loaded cost of a specialist's time, even partially displaced, remains cheaper than the AI system plus required oversight for this complex, liability-sensitive task.
Cost vs. human wage	claude-sonnet-5	2/5	AI can cut drafting time but human oversight, coordination, and liability review remain necessary, so overall cost savings versus a specialist's loaded wage are modest.
Technical feasibility today	claude-haiku-4-5-20251001	2/5	Document drafting and assembly tools exist, but no deployed product reliably coordinates the full multi-party preparation workflow, manages version control across teams, or makes strategic decisions about regulatory positioning without substantial human oversight and correction.
Technical feasibility today	claude-sonnet-5	2/5	Some document-drafting and compliance-checking tools exist in regulatory affairs software, but no deployed product autonomously coordinates the full multi-stakeholder submission process reliably.

Communicate with regulatory agencies regarding pre-submission strategies, potential regulatory pathways, compliance test requirements, or clarification and follow-up of submissions under review.

CI 25–25 · exposure 25 · augmentation 75 · importance 4.5/5 · click for rater detail

Panel ratings per dimension for this task
Dimension	Model	Rating	Rationale
Sector adoption velocity	claude-haiku-4-5-20251001	2/5	Regulatory affairs remains a conservative, relationship-dependent function where compliance errors carry high costs and reputational risk. Adoption of AI for these communications is still in pilot phases; most organizations rely on human specialists for direct agency interaction, reflecting organizational and regulatory friction.
Sector adoption velocity	claude-sonnet-5	2/5	Regulatory affairs is a compliance-heavy, conservative function within highly regulated industries (pharma, medical devices) with slow AI adoption for external-facing regulatory communication specifically.
Augmentation potential	claude-haiku-4-5-20251001	4/5	AI significantly augments regulatory specialists by drafting documents, analyzing regulatory databases, summarizing pathway options, and flagging compliance gaps—tasks that occupy substantial specialist time. The human remains essential for strategy and agency contact, but AI raises productivity on preparation and research substantially.
Augmentation potential	claude-sonnet-5	4/5	AI can meaningfully assist by drafting correspondence, summarizing regulations, tracking submission status, and suggesting pathway strategies, significantly boosting specialist productivity while they remain the accountable communicator.
Task automatability	claude-haiku-4-5-20251001	2/5	While AI can draft compliance documents and summarize regulatory pathways, the task requires strategic judgment, real-time relationship management, and nuanced communication with government agencies that depends on context-specific knowledge and negotiation. Current AI cannot independently conduct these communications and achieve compliance outcomes at equal quality to human specialists.
Task automatability	claude-sonnet-5	2/5	This requires real-time strategic dialogue with regulators, judgment on evolving agency feedback, and accountability for representations made—AI can draft communications but cannot conduct the actual regulatory relationship or agency interactions end-to-end.
Adoption barriers	claude-haiku-4-5-20251001	4/5	Regulatory agencies typically require direct communication with authorized company representatives, and many jurisdictions impose liability requirements on human signoffs for pre-submissions and compliance strategies. Professional trust, continuity of contact, and legal accountability create strong barriers to full automation.
Adoption barriers	claude-sonnet-5	4/5	Regulatory agencies typically require designated, often credentialed, company representatives for official communications, and errors carry significant compliance and liability risk, creating strong barriers to full automation.
Cost vs. human wage	claude-haiku-4-5-20251001	2/5	AI-generated compliance documents and pathway analysis have meaningful oversight costs, and regulatory specialists earn substantial salaries. Even with AI assistance, human review and final communication with agencies remains mandatory, keeping total cost-per-outcome comparable to or higher than direct human performance.
Cost vs. human wage	claude-sonnet-5	2/5	While AI can cut drafting time, the task still requires a credentialed specialist to engage with agencies, sign submissions, and bear liability, so overall cost savings are modest relative to the human's continued involvement.
Technical feasibility today	claude-haiku-4-5-20251001	2/5	No deployed products reliably perform end-to-end regulatory agency communication independently. AI tools can assist with document drafting and pathway research, but regulatory agencies expect direct human contact, and the stakes of miscommunication are high. Products exist for supporting steps, but not for autonomous execution of the full task.
Technical feasibility today	claude-sonnet-5	2/5	AI tools assist with drafting correspondence and researching regulatory pathways, but no deployed product independently communicates with agencies like FDA/EMA on a company's behalf; humans must serve as the official contact.

Prepare or direct the preparation of additional information or responses as requested by regulatory agencies.

CI 25–25 · exposure 25 · augmentation 75 · importance 4.5/5 · click for rater detail

Panel ratings per dimension for this task
Dimension	Model	Rating	Rationale
Sector adoption velocity	claude-haiku-4-5-20251001	2/5	Regulatory affairs operates in highly regulated sectors (pharma, medical devices, finance) with slow, risk-averse IT adoption and conservative cultures. Pilot projects exist but production deployment of autonomous regulatory response systems is rare; human specialists remain the norm due to compliance risk.
Sector adoption velocity	claude-sonnet-5	2/5	Life sciences and regulated industries are cautious adopters of AI for compliance-critical documentation, with pilots emerging but production-scale deployment for agency-facing responses still limited.
Augmentation potential	claude-haiku-4-5-20251001	4/5	AI can meaningfully assist specialists by accelerating information retrieval, generating response drafts, checking regulatory requirement consistency, and flagging potential gaps—raising productivity without removing human judgment or sign-off authority. Specialists can review and refine AI-assisted drafts faster than creating responses from scratch.
Augmentation potential	claude-sonnet-5	4/5	AI can meaningfully assist by drafting initial responses, summarizing prior submissions, and organizing supporting data, substantially speeding up the specialist's workflow while they retain final judgment.
Task automatability	claude-haiku-4-5-20251001	2/5	While AI can draft portions of regulatory responses and gather relevant information, regulatory submissions require domain expertise, legal precision, and understanding of specific agency requirements that vary by jurisdiction and product type. The task involves judgment calls about what information is material and how to frame it, which remains heavily dependent on human oversight today.
Task automatability	claude-sonnet-5	2/5	Drafting responses to regulatory queries requires synthesizing technical data, legal interpretation, and strategic judgment tailored to agency concerns, which current AI can assist with but not reliably execute end-to-end at equal quality.
Adoption barriers	claude-haiku-4-5-20251001	4/5	Regulatory agencies often require submissions to be prepared by or signed off by qualified personnel, creating legal and liability barriers to full automation. Failure to comply with agency requests or provide accurate information carries legal and financial consequences, making organizations reluctant to remove human oversight.
Adoption barriers	claude-sonnet-5	4/5	Regulatory submissions typically require sign-off by qualified, often credentialed professionals, and errors carry significant legal and safety consequences, creating strong accountability barriers to full automation.
Cost vs. human wage	claude-haiku-4-5-20251001	2/5	Current AI tools reduce time on drafting and research components, but the specialist's labor remains substantial because legal review, regulatory interpretation, and quality assurance cannot be substituted. All-in cost of AI assistance with human oversight is likely still higher than or comparable to traditional specialist labor for complex submissions.
Cost vs. human wage	claude-sonnet-5	2/5	Because human regulatory experts must review, validate, and take accountability for submissions, AI only reduces drafting time modestly while oversight and liability costs keep overall cost comparable to human-led processes.
Technical feasibility today	claude-haiku-4-5-20251001	2/5	No deployed product reliably handles end-to-end preparation of regulatory responses at production scale; existing AI tools can assist with drafting and information retrieval but require significant human review and legal judgment. Regulatory affairs remains a domain where stakes are high and error costs are severe, limiting autonomous deployment.
Technical feasibility today	claude-sonnet-5	2/5	AI writing tools can draft portions of regulatory correspondence, but no deployed product autonomously manages full regulatory response cycles including data gathering, compliance verification, and submission in production at scale.

Coordinate, prepare, or review regulatory submissions for domestic or international projects.

CI 25–25 · exposure 25 · augmentation 75 · importance 4.5/5 · click for rater detail

Panel ratings per dimension for this task
Dimension	Model	Rating	Rationale
Sector adoption velocity	claude-haiku-4-5-20251001	2/5	Regulatory affairs is a conservative, compliance-heavy domain with strong institutional risk aversion; while large pharma and life sciences firms are piloting AI-assisted review tools, widespread production adoption remains limited and adoption velocity is slow due to liability concerns and regulatory skepticism.
Sector adoption velocity	claude-sonnet-5	2/5	Regulatory affairs is a conservative, compliance-heavy field with cautious AI adoption; pilots for document automation exist but production-scale autonomous submission handling remains rare.
Augmentation potential	claude-haiku-4-5-20251001	4/5	AI demonstrates strong potential to augment regulatory specialists by automating document drafting, compliance checklist generation, cross-referencing regulations, and flagging inconsistencies, allowing experts to focus on strategic judgment, stakeholder engagement, and complex risk assessment while maintaining human oversight and final authority.
Augmentation potential	claude-sonnet-5	4/5	AI significantly aids drafting, formatting, cross-referencing regulations, and identifying inconsistencies, meaningfully boosting specialist productivity while humans retain final responsibility.
Task automatability	claude-haiku-4-5-20251001	2/5	While AI can assist with drafting and reviewing components of regulatory submissions (e.g., formatting, compliance checklist validation), the task requires deep contextual judgment about project-specific regulatory pathways, stakeholder requirements, and risk assessment that current AI systems cannot reliably perform end-to-end without substantial human oversight and domain expertise.
Task automatability	claude-sonnet-5	2/5	AI can draft portions of regulatory submissions and organize supporting documentation, but coordinating cross-functional input, ensuring regulatory strategy alignment, and final review require human judgment and accountability that current systems cannot fully replace.
Adoption barriers	claude-haiku-4-5-20251001	4/5	Regulatory submissions typically must be signed and certified by licensed regulatory affairs professionals or officers who bear legal and compliance liability; many jurisdictions require human accountability and expert sign-off, creating a hard barrier to full automation regardless of technical capability.
Adoption barriers	claude-sonnet-5	4/5	Regulatory submissions often require sign-off by licensed or qualified regulatory professionals and are subject to strict agency requirements (e.g., FDA, EMA), creating substantial legal and compliance barriers to full automation.
Cost vs. human wage	claude-haiku-4-5-20251001	2/5	Current AI tools reduce some labor on drafting and formatting but still require expert human review, quality assurance, and decision-making; the all-in cost of AI-assisted submission preparation (inference, integration, mandatory human oversight) remains comparable to or higher than hiring junior regulatory staff for routine portions.
Cost vs. human wage	claude-sonnet-5	2/5	AI tools can reduce drafting time but the need for extensive human verification, legal review, and liability management keeps overall costs closer to human-led processes rather than dramatically cheaper.
Technical feasibility today	claude-haiku-4-5-20251001	2/5	No mature product reliably coordinates and reviews entire regulatory submissions end-to-end in production; while AI tools exist for document drafting and basic compliance checking, they are narrow in scope and require significant human verification, particularly for complex international submissions with sector-specific requirements.
Technical feasibility today	claude-sonnet-5	2/5	Some AI-assisted document drafting and compliance-checking tools exist in regulatory affairs software, but no deployed product reliably handles full submission coordination and review across jurisdictions without heavy human oversight.

Determine the types of regulatory submissions or internal documentation that are required in situations such as proposed device changes or labeling changes.

CI 25–25 · exposure 25 · augmentation 63 · importance 4.4/5 · click for rater detail

Panel ratings per dimension for this task
Dimension	Model	Rating	Rationale
Sector adoption velocity	claude-haiku-4-5-20251001	2/5	Pharmaceutical and medical device sectors are heavily regulated and risk-averse; adoption of autonomous AI for regulatory determinations remains slow, with most firms using AI as a junior-level research tool under strict expert validation rather than deploying it as an independent decision-maker.
Sector adoption velocity	claude-sonnet-5	2/5	Highly regulated life sciences/med-device sectors adopt AI cautiously, especially for compliance-critical judgment tasks, so uptake is slow relative to sectors like general software or finance analytics.
Augmentation potential	claude-haiku-4-5-20251001	3/5	AI can meaningfully assist by rapidly surveying regulatory guidance documents, flagging relevant precedents, and generating preliminary checklists, but the specialist retains responsibility for final determination and must verify all recommendations against current regulations and device-specific context.
Augmentation potential	claude-sonnet-5	4/5	AI can meaningfully help specialists research applicable regulations, precedents, and draft documentation checklists, improving speed and thoroughness while human judgment finalizes decisions.
Task automatability	claude-haiku-4-5-20251001	2/5	While AI can assist in identifying relevant regulations and templates for common scenarios, this task fundamentally requires expert judgment to determine which specific submissions apply to a particular proposed change. The decision involves contextual understanding of device characteristics, regulatory pathways, and risk profiles that current AI systems handle inconsistently without human oversight.
Task automatability	claude-sonnet-5	2/5	This requires interpreting complex, jurisdiction-specific regulatory frameworks and applying judgment to novel situations; AI can assist but not reliably determine submission requirements end-to-end without expert verification.
Adoption barriers	claude-haiku-4-5-20251001	4/5	Significant barriers exist: regulatory specialists may be subject to professional licensing in some jurisdictions, legal liability falls on the organization for incorrect submission determinations, and most organizations legally require expert sign-off on regulatory submissions before filing with authorities.
Adoption barriers	claude-sonnet-5	4/5	Regulatory submission decisions often require credentialed/experienced regulatory affairs professionals and carry major liability if wrong, creating strong human-in-the-loop requirements.
Cost vs. human wage	claude-haiku-4-5-20251001	2/5	AI tools for regulatory compliance are specialized and costly to implement and maintain, while regulatory specialists' expertise commands high salaries; the all-in cost of AI solutions currently remains comparable to or exceeds the cost of human review.
Cost vs. human wage	claude-sonnet-5	2/5	AI tools can reduce research time, but the need for human regulatory expert review to confirm correctness limits cost savings relative to labor-intensive verification.
Technical feasibility today	claude-haiku-4-5-20251001	2/5	No mature product reliably performs this task end-to-end in production. Regulatory guidance systems exist as research tools and limited enterprise solutions, but they require substantial human review and often produce incomplete or overly broad recommendations rather than precise, actionable determinations.
Technical feasibility today	claude-sonnet-5	2/5	Some regulatory-intelligence software and LLM-based tools exist to suggest applicable pathways, but none reliably operate in production without specialist oversight due to high error costs and regulatory nuance.

Advise project teams on subjects such as premarket regulatory requirements, export and labeling requirements, or clinical study compliance issues.

CI 25–25 · exposure 25 · augmentation 75 · importance 4.3/5 · click for rater detail

Panel ratings per dimension for this task
Dimension	Model	Rating	Rationale
Sector adoption velocity	claude-haiku-4-5-20251001	2/5	Regulatory affairs is a compliance-critical, relationship-heavy function in highly regulated industries (pharma, medical devices, food); adoption of AI-only advisory is minimal and adoption of AI-assisted work is cautious, driven by risk-averse institutional culture and liability concerns rather than speed-to-adoption sectors.
Sector adoption velocity	claude-sonnet-5	2/5	Life sciences and medical device regulatory functions are historically slow to adopt AI due to compliance risk aversion, though pilot use of AI research tools is growing.
Augmentation potential	claude-haiku-4-5-20251001	4/5	AI excels at accelerating regulatory research, organizing complex requirement documents, flagging potential compliance issues, and drafting initial compliance narratives—tasks that free specialists to focus on strategy, stakeholder negotiation, and judgment calls; this is a natural high-leverage augmentation scenario.
Augmentation potential	claude-sonnet-5	4/5	AI tools substantially speed up literature/regulation research, drafting summaries, and flagging relevant requirements, meaningfully boosting specialist productivity while humans retain final judgment.
Task automatability	claude-haiku-4-5-20251001	2/5	AI can draft initial regulatory summaries and flag some compliance considerations, but the task requires nuanced interpretation of evolving regulations, judgment calls on gray areas, and accountability for advice that affects product approval and legal liability—areas where current AI systems lack sufficient reliability and cannot take responsibility for outcomes.
Task automatability	claude-sonnet-5	2/5	AI can retrieve and summarize regulatory requirements but advising project teams requires contextual judgment, interpretation of ambiguous regulations, and accountability that current systems cannot fully replicate end-to-end.
Adoption barriers	claude-haiku-4-5-20251001	4/5	Regulatory affairs advice often requires professional certification or legal defensibility; companies face liability if non-expert or AI-only guidance leads to non-compliance; regulatory bodies and corporate counsel typically require a named human responsible for compliance sign-off, creating a hard barrier to full automation.
Adoption barriers	claude-sonnet-5	4/5	Regulatory advice often requires credentialed expertise and carries significant liability exposure (e.g., FDA submissions, export control violations), creating strong organizational and legal barriers to full automation.
Cost vs. human wage	claude-haiku-4-5-20251001	2/5	AI tools can assist with research and drafting, but the specialist's loaded wage (~$80–150k) includes legal accountability and expert judgment that automation cannot replace; cost per fully independent AI-driven advisory remains higher than the human when accounting for required oversight and liability risk.
Cost vs. human wage	claude-sonnet-5	2/5	AI can cheaply generate draft summaries or flag requirements, but the need for expert verification and liability review keeps effective all-in cost closer to human specialist cost.
Technical feasibility today	claude-haiku-4-5-20251001	2/5	While generative AI can retrieve regulatory information and summarize requirements, no deployed product reliably advises on complex, high-stakes regulatory strategy without human expert review; regulatory consultancy in production still requires licensed specialists to validate and own the advice.
Technical feasibility today	claude-sonnet-5	2/5	Products like regulatory intelligence tools and LLM-based compliance assistants exist and are used for research support, but no deployed system reliably provides authoritative regulatory advice without heavy human review.

Review clinical protocols to ensure collection of data needed for regulatory submissions.

CI 25–25 · exposure 25 · augmentation 63 · importance 4.0/5 · click for rater detail

Panel ratings per dimension for this task
Dimension	Model	Rating	Rationale
Sector adoption velocity	claude-haiku-4-5-20251001	2/5	Pharmaceutical and biotech companies are cautious adopters of AI in regulatory workflows due to compliance sensitivity. While pilots and assistive tools are emerging, production displacement of regulatory review remains limited; the sector remains in early pilot stages rather than deep deployment.
Sector adoption velocity	claude-sonnet-5	2/5	Pharma and biotech regulatory affairs are historically slow-moving, risk-averse, and highly regulated, with AI adoption mostly at pilot stage for document review rather than deep production use.
Augmentation potential	claude-haiku-4-5-20251001	3/5	AI can usefully assist by cross-referencing protocols against regulatory checklists, flagging missing data elements, and highlighting inconsistencies, allowing specialists to focus on judgment-heavy interpretation. However, augmentation is limited to parts of the workflow rather than transformative across the full task.
Augmentation potential	claude-sonnet-5	4/5	AI can meaningfully assist by cross-referencing protocols against regulatory checklists and past submissions, helping specialists work faster and catch errors, while final judgment remains human.
Task automatability	claude-haiku-4-5-20251001	2/5	AI can assist with identifying missing data fields and comparing protocols against regulatory templates, but the nuanced interpretation of clinical protocols and regulatory requirements—especially in their domain-specific context—requires substantial human judgment. A full end-to-end autonomous review would likely miss context-dependent compliance issues.
Task automatability	claude-sonnet-5	2/5	AI can flag missing data elements or inconsistencies against regulatory templates, but judgment about clinical relevance, submission strategy, and risk requires human expertise and accountability, limiting full end-to-end automation.dez
Adoption barriers	claude-haiku-4-5-20251001	4/5	Regulatory compliance in clinical submissions is heavily governed by FDA, EMA, and other agency rules; errors carry substantial liability and financial risk. There is no legal requirement for a licensed human sign-off on the final review, but organizational risk aversion, liability asymmetry, and the criticality of accuracy create strong de facto barriers to full automation.
Adoption barriers	claude-sonnet-5	4/5	Regulatory submissions require qualified professionals to certify protocol adequacy, and errors can cause costly delays or rejections, creating strong liability and compliance-driven barriers to full automation.
Cost vs. human wage	claude-haiku-4-5-20251001	2/5	Regulatory affairs specialists command high loaded wages (typically $120k–$180k+ annually), and AI tooling plus required human oversight still represents a significant cost. Savings are modest because oversight and error-correction by domain experts remain necessary.
Cost vs. human wage	claude-sonnet-5	2/5	AI tools can cheaply scan for obvious gaps, but the overall task still requires expensive specialist review and sign-off, so total cost savings versus a human specialist are modest.
Technical feasibility today	claude-haiku-4-5-20251001	2/5	Document analysis tools and LLMs can extract and flag content from protocols, but no deployed system reliably performs end-to-end regulatory protocol review with the accuracy required for submission compliance. Existing products require heavy human verification and lack the legal and scientific grounding needed for production use.
Technical feasibility today	claude-sonnet-5	2/5	Some document-review and compliance-checking tools exist for regulatory documents, but no mature product reliably performs comprehensive protocol review for regulatory data adequacy in production without heavy human oversight.

Determine requirements applying to treatment, storage, shipment, or disposal of potentially hazardous production-related waste.

CI 25–25 · exposure 25 · augmentation 63 · importance 3.3/5 · click for rater detail

Panel ratings per dimension for this task
Dimension	Model	Rating	Rationale
Sector adoption velocity	claude-haiku-4-5-20251001	2/5	Adoption of AI in regulatory affairs remains slow and cautious; most deployments are assistive (drafting, summarization) rather than autonomous determination. Risk-averse compliance departments favor human expertise and documented accountability, limiting rapid AI substitution.
Sector adoption velocity	claude-sonnet-5	2/5	Regulatory affairs and EHS compliance functions in manufacturing/industrial sectors adopt AI slowly, with pilots emerging in document review but production-scale determination systems still uncommon.
Augmentation potential	claude-haiku-4-5-20251001	3/5	AI can meaningfully assist by surfacing relevant regulations, organizing requirements by jurisdiction, and flagging potential gaps, allowing specialists to focus on interpretation and decision-making. However, the final determination remains fundamentally a human judgment task.
Augmentation potential	claude-sonnet-5	4/5	AI tools can efficiently search, summarize, and cross-reference regulatory text and past determinations, substantially speeding up a specialist's research and drafting process while the human retains final judgment.
Task automatability	claude-haiku-4-5-20251001	2/5	While AI can retrieve and summarize regulatory text on waste handling requirements from static sources, it struggles with context-specific interpretation, jurisdiction-dependent variations, and integration with an organization's particular processes and materials. The task requires resolving ambiguities in multi-layered regulations that current AI cannot reliably do end-to-end without substantial human oversight.
Task automatability	claude-sonnet-5	2/5	Determining applicable regulatory requirements involves synthesizing complex, jurisdiction-specific rules and applying judgment to specific waste streams and facility contexts, which AI can support but not fully execute end-to-end reliably today.atch
Adoption barriers	claude-haiku-4-5-20251001	4/5	Regulatory affairs has high liability and error-cost asymmetry; incorrect waste-disposal determinations carry legal, environmental, and financial penalties. Many jurisdictions require a qualified, licensed professional to certify compliance determinations, creating hard authorization barriers to full automation.
Adoption barriers	claude-sonnet-5	4/5	Hazardous waste compliance is heavily regulated (RCRA, EPA, state agencies) with legal liability for misclassification, typically requiring sign-off by qualified regulatory professionals, creating strong barriers to full automation.
Cost vs. human wage	claude-haiku-4-5-20251001	2/5	Current AI compliance tools require significant human validation and oversight to avoid costly regulatory breaches. When factoring integration, ongoing model updates, and mandatory expert review, the total cost per reliable determination often approaches or exceeds the loaded cost of a specialist performing the analysis directly.
Cost vs. human wage	claude-sonnet-5	2/5	AI can cheaply search and summarize regulations, but the need for expert verification and liability review means the effective all-in cost remains close to or above dedicated specialist labor for this task.
Technical feasibility today	claude-haiku-4-5-20251001	2/5	Some regulatory-document AI and compliance tools exist in production, but they are primarily search and summarization aids rather than reliable determiners of requirements. Error rates on novel waste streams or cross-jurisdictional scenarios remain material; deployment typically requires legal/specialist review rather than autonomous operation.
Technical feasibility today	claude-sonnet-5	2/5	Some compliance-research and document-retrieval tools exist, but no deployed product reliably determines authoritative hazardous waste requirements without significant human verification given regulatory complexity and liability stakes.

Specialize in regulatory issues related to agriculture, such as the cultivation of green biotechnology crops or the post-market regulation of genetically altered crops.

CI 25–25 · exposure 25 · augmentation 75 · importance 2.4/5 · click for rater detail

Panel ratings per dimension for this task
Dimension	Model	Rating	Rationale
Sector adoption velocity	claude-haiku-4-5-20251001	2/5	Pharmaceutical and agricultural biotech companies are beginning to pilot AI for document processing and research, but adoption of AI-driven regulatory decision-making remains cautious due to compliance risk and the conservative nature of regulatory operations.
Sector adoption velocity	claude-sonnet-5	2/5	Agriculture and specialized regulatory affairs are not fast-adopting sectors for AI; adoption is nascent with few production-grade tools tailored to this niche domain.
Augmentation potential	claude-haiku-4-5-20251001	4/5	AI significantly augments regulatory specialists by automating literature review, summarizing regulatory guidance, drafting compliance documentation, and flagging relevant precedents—freeing specialists to focus on strategy, stakeholder management, and complex interpretive judgment.
Augmentation potential	claude-sonnet-5	4/5	AI can meaningfully assist by rapidly synthesizing regulatory texts, tracking policy changes, and drafting documentation, significantly boosting the efficiency of specialists who retain final judgment.
Task automatability	claude-haiku-4-5-20251001	2/5	AI can assist with regulatory document research, precedent analysis, and draft preparation, but cannot autonomously handle the nuanced interpretation of biotechnology regulations, stakeholder engagement, and strategic decision-making that the task requires. The task involves specialization in complex, evolving regulatory frameworks where judgment and legal accountability remain essential.
Task automatability	claude-sonnet-5	2/5	AI can assist with research, drafting, and summarizing regulations, but the specialized judgment needed to interpret novel biotech regulatory frameworks, engage with agencies, and manage post-market compliance requires deep domain expertise and accountability AI cannot fully replicate.
Adoption barriers	claude-haiku-4-5-20251001	4/5	Regulatory affairs in biotechnology involves statutory requirements for human expert review, legal liability for non-compliance, and often formal signatory authority by licensed professionals. Regulatory bodies typically require accountable human judgment and sign-off on regulatory submissions and compliance decisions.
Adoption barriers	claude-sonnet-5	4/5	Regulatory submissions to bodies like USDA/APHIS or EPA typically require credentialed professionals to certify accuracy, and liability for regulatory errors in biotech crops is high, creating strong barriers to full automation.
Cost vs. human wage	claude-haiku-4-5-20251001	2/5	AI tools for regulatory research and document drafting are relatively inexpensive, but the specialized expertise, legal liability, and ongoing human oversight required for regulatory affairs mean total cost savings remain modest compared to using junior regulatory staff for support tasks.
Cost vs. human wage	claude-sonnet-5	2/5	While AI can cut research and drafting time, the niche expertise and need for human validation of regulatory submissions mean overall costs remain comparable to specialized human labor, not dramatically cheaper.
Technical feasibility today	claude-haiku-4-5-20251001	2/5	While AI tools can support document review and data gathering, no deployed product reliably performs end-to-end regulatory strategy for biotech crops without human oversight. Regulatory compliance in this domain is too high-stakes and context-dependent for current systems to operate independently.
Technical feasibility today	claude-sonnet-5	2/5	No deployed products specifically handle agricultural biotech regulatory affairs end-to-end; general-purpose AI and compliance tools offer only partial, unreliable support for this narrow specialty.

Determine the legal implications of the production, supply, or use of ozone-depleting substances or equipment containing such substances.

CI 20–25 · exposure 25 · augmentation 63 · importance 2.2/5 · click for rater detail

Panel ratings per dimension for this task
Dimension	Model	Rating	Rationale
Sector adoption velocity	claude-haiku-4-5-20251001	2/5	Regulatory affairs remains a specialized, risk-averse function with slow AI adoption; compliance-critical decisions are typically handled by established regulatory teams with little incentive to automate high-stakes legal determinations without substantial validated precedent.
Sector adoption velocity	claude-sonnet-5	2/5	Regulatory affairs in chemical/environmental compliance sectors adopts AI tools slowly, with pilots for research assistance but limited production deployment for legal determination tasks.
Augmentation potential	claude-haiku-4-5-20251001	3/5	AI can assist by rapidly searching and categorizing ozone-depletion regulations, flagging relevant substances in product inventories, and drafting regulatory summaries, improving a specialist's research efficiency while they retain judgment on final legal implications.
Augmentation potential	claude-sonnet-5	4/5	AI can significantly speed up research into applicable regulations, precedent, and documentation, meaningfully aiding specialists even though final legal determination remains human-led.
Task automatability	claude-haiku-4-5-20251001	2/5	While AI can retrieve and summarize ozone-depletion regulations and identify substance classifications, determining legal implications requires contextual judgment about specific production scenarios, contractual obligations, and jurisdiction-specific enforcement risks that currently demand human legal reasoning and accountability.
Task automatability	claude-sonnet-5	2/5	This requires interpreting layered, jurisdiction-specific regulatory frameworks (Montreal Protocol, EPA rules, etc.) and applying legal judgment to specific facts, which current AI can support but not reliably complete end-to-end at production quality.
Adoption barriers	claude-haiku-4-5-20251001	5/5	Strong regulatory and liability barriers apply: regulatory affairs specialists often must hold professional credentials, and incorrect legal implications can expose organizations to environmental penalties and litigation, requiring human accountability and sign-off by authorized personnel.
Adoption barriers	claude-sonnet-5	4/5	Regulatory compliance determinations often carry legal liability and may require sign-off by qualified regulatory/legal professionals, creating strong barriers to full automation.
Cost vs. human wage	claude-haiku-4-5-20251001	2/5	AI can reduce research time modestly, but the final legal determination still requires a qualified specialist's review and sign-off, meaning total cost (AI plus human oversight) remains comparable to or higher than traditional specialist labor for this regulated domain.
Cost vs. human wage	claude-sonnet-5	2/5	AI can cheaply surface relevant regulatory text, but the analysis still requires expensive expert oversight to validate legal conclusions, keeping overall cost comparable to or only modestly below human-only work.
Technical feasibility today	claude-haiku-4-5-20251001	2/5	No deployed product reliably performs end-to-end legal implication analysis for ozone-depletion compliance; AI systems can assist with regulatory lookup and document review but require human legal expertise to render defensible opinions on liability and compliance status.
Technical feasibility today	claude-sonnet-5	2/5	AI legal research and compliance tools exist and can retrieve relevant regulations, but no deployed product reliably determines legal implications for specific ozone-depleting substance scenarios without expert review.

Coordinate recall or market withdrawal activities as necessary.

CI 11–29 · exposure 28 · augmentation 63 · importance 4.4/5 · click for rater detail

Panel ratings per dimension for this task
Dimension	Model	Rating	Rationale
Sector adoption velocity	claude-haiku-4-5-20251001	2/5	Adoption of AI-assisted tools in regulatory affairs is slow and cautious. Organizations use AI for document drafting and data organization, but human specialists remain the decision-maker and authority. Sectors (pharmaceuticals, medical devices, food) are highly regulated and risk-averse, limiting automation velocity.
Sector adoption velocity	claude-sonnet-5	2/5	Regulatory affairs functions in pharma/medical device/consumer goods sectors adopt AI slowly for compliance-critical tasks due to liability and regulatory scrutiny, with pilots limited mostly to document management.
Augmentation potential	claude-haiku-4-5-20251001	4/5	AI significantly augments specialist productivity by automating draft notices, consolidating regulatory data, generating stakeholder communication templates, and tracking batch/lot information. The specialist retains judgment and sign-off authority while AI handles time-consuming coordination logistics, raising overall throughput and reducing manual work.
Augmentation potential	claude-sonnet-5	3/5	AI can help draft recall notices, track distribution records, and analyze complaint data to support faster decision-making, meaningfully aiding parts of the coordination task.
Task automatability	claude-haiku-4-5-20251001	3/5	AI can partially automate recall coordination: generating notices, drafting communications, organizing timelines, and tracking inventory/batch data. However, the task requires significant judgment—legal assessment of risk severity, stakeholder negotiation, decision-making under regulatory ambiguity—that necessitates human expertise and accountability.
Task automatability	claude-sonnet-5	2/5	Coordinating a recall involves cross-functional decision-making, regulatory judgment, negotiation with agencies, and crisis management that current AI cannot execute end-to-end, though it can assist with documentation and tracking.
Adoption barriers	claude-haiku-4-5-20251001	5/5	Strong legal and regulatory barriers protect this task: regulatory agencies (FDA, CPSC, etc.) require a licensed or authorized human agent to initiate and sign off on recalls; liability and legal responsibility cannot be delegated to AI; organizational protocols mandate human accountability for market safety decisions.
Adoption barriers	claude-sonnet-5	5/5	Recalls are heavily regulated (e.g., FDA, CPSC) and require accountable human sign-off, legal liability considerations, and formal reporting that mandate qualified human oversight.
Cost vs. human wage	claude-haiku-4-5-20251001	2/5	AI tools (document automation, workflow tracking) reduce overhead costs on routine coordination tasks, but the specialist salary remains the primary cost. Full substitution is neither feasible nor legally permissible, so the cost advantage is modest—roughly comparable when accounting for human oversight and integration overhead.
Cost vs. human wage	claude-sonnet-5	1/5	Given the liability, coordination complexity, and need for expert judgment, AI cannot substitute for the human labor involved, making cost comparisons favor human specialists overseeing the process.
Technical feasibility today	claude-haiku-4-5-20251001	2/5	While AI can draft templates and manage communication logistics, no deployed product reliably orchestrates end-to-end recall coordination with the requisite legal judgment and stakeholder coordination. Existing tools assist with document generation and tracking but do not replace the human regulatory specialist's decision authority.
Technical feasibility today	claude-sonnet-5	1/5	No deployed product autonomously coordinates product recalls; this remains a human-led, high-stakes operational and regulatory process with no mature automation offering.

Direct the collection and preparation of laboratory samples as requested by regulatory agencies.

CI 0–20 · exposure 8 · augmentation 38 · importance 3.2/5 · click for rater detail

Panel ratings per dimension for this task
Dimension	Model	Rating	Rationale
Sector adoption velocity	claude-haiku-4-5-20251001	1/5	Pharmaceutical and laboratory regulatory affairs remain heavily rule-bound and human-supervised. Adoption of automation in sample collection direction is negligible because regulatory frameworks mandate human oversight and sign-off.
Sector adoption velocity	claude-sonnet-5	2/5	Regulatory affairs and lab operations sectors are moderate-to-slow adopters of AI for physical and compliance-heavy workflows compared to fully digital domains.
Augmentation potential	claude-haiku-4-5-20251001	2/5	AI could assist with documentation, regulatory requirement lookup, and checklist generation, but the core task of directing and coordinating sample handling remains human-led. Augmentation potential is limited to administrative support around the central supervisory function.
Augmentation potential	claude-sonnet-5	3/5	AI can help generate sampling protocols, checklists, and documentation templates, improving efficiency even though the physical direction of collection remains human-led.
Task automatability	claude-haiku-4-5-20251001	1/5	Directing the collection and preparation of laboratory samples requires hands-on coordination with physical materials, interpretation of regulatory nuances, and real-time decision-making in a laboratory environment. Current AI systems cannot physically handle samples or supervise technicians in real facilities.
Task automatability	claude-sonnet-5	2/5	The task involves directing physical logistics, coordinating personnel, and ensuring chain-of-custody compliance, which requires human oversight and cannot be fully automated by current AI systems.
Adoption barriers	claude-haiku-4-5-20251001	5/5	Regulatory agencies typically require a licensed or qualified human specialist to direct and certify sample collection and preparation procedures. Legal liability, compliance accountability, and explicit regulatory authority vest in the human regulator, creating hard substitution barriers.
Adoption barriers	claude-sonnet-5	4/5	Regulatory sample collection often requires accountability from a qualified/authorized person and strict chain-of-custody protocols, creating strong organizational and compliance barriers to automation.
Cost vs. human wage	claude-haiku-4-5-20251001	1/5	AI systems cannot perform the core supervisory and physical-world coordination functions required, making them unsuitable as a cost replacement. Any AI support would be narrow (documentation) and would not reduce the need for a human director.
Cost vs. human wage	claude-sonnet-5	2/5	AI could assist with documentation and scheduling but the physical direction and coordination of sample collection still require human labor, so cost savings are limited.
Technical feasibility today	claude-haiku-4-5-20251001	1/5	No deployed product autonomously directs laboratory sample collection and preparation in compliance with regulatory requirements. This task involves domain expertise, regulatory interpretation, and supervisory authority that remain entirely human-dependent.
Technical feasibility today	claude-sonnet-5	1/5	No deployed AI product directs physical laboratory sample collection or coordinates cross-functional teams to meet regulatory sampling requests today.

Related occupations — Business & Financial Operations

How to read this

A high substitution score does not mean this job disappears — it means a large share of its current tasks face replacement pressure, so the mix of tasks is likely to change. High augmentation alongside substitution typically means the occupation reorganizes around the protected tasks. Wide confidence intervals mean the rater panel disagreed: treat those scores as open questions, not verdicts.

What would change this score

New model capabilities (automatability, feasibility), falling inference costs (cost ratio), regulation and licensing shifts (barriers), and measured sector adoption (velocity) all re-enter at every index release. Each release is recomputed, versioned and kept queryable — scores are claims with a date on them, not permanent labels.